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Granzyme B (GzmB) is a protease with a well-chara-
cterized intracellular role in targeted destruction of
compromised cells by cytotoxic lymphocytes. How-
ever, GzmB also cleaves extracellular matrix com-
ponents, suggesting that it influences the interplay
between cytotoxic lymphocytes and their environ-
ment. Here, we show that GzmB-null effector T cells
and natural killer (NK) cells exhibited a cell-autono-
mous homing deficit in mouse models of inflamma-
tion and Ectromelia virus infection. Intravital imaging
of effector T cells in inflamed cremaster muscle ve-
nules revealed that GzmB-null cells adhered normally
to the vessel wall and could extend lamellipodia
through it but did not cross it efficiently. In vitro
migration assays showed that active GzmB was
released from migrating cytotoxic lymphocytes and
enabled chemokine-driven movement through base-
ment membranes. Finally, proteomic analysis de-
monstrated that GzmB cleaved basementmembrane
constituents. Our results highlight an important role
for GzmB in expediting cytotoxic lymphocyte diape-
desis via basement membrane remodeling.
INTRODUCTION
Cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells,
collectively known as cytotoxic lymphocytes, eliminate foreign,
infected, or neoplastic cells. A killing mechanism used by cyto-
toxic lymphocytes involves perforin-mediated delivery of prote-
ases (granzymes) from the degranulating cytotoxic lymphocyte
into the cytoplasm of the target cell, resulting in target cell death.
Granzyme B (GzmB) is the best characterized granzyme: it is a
widely used activation marker of both CTLs and NK cells and
is a potent cytotoxin mediating target cell apoptosis, primarily960 Immunity 41, 960–972, December 18, 2014 ª2014 Elsevier Inc.via caspase activation. It has also been implicated in immune
regulation via regulatory-T-cell-mediated suppression of acti-
vated cells and elimination of T helper (Th) cells by activation-
induced cell death (Cao et al., 2007; Devadas et al., 2006).
Recent evidence suggests that granzymes have broader roles
(Joeckel and Bird, 2014). For example, GzmB is present in many
noncytotoxic immune cell types (Table S1, available online), its
relative importance in direct target cell killing in vivo has been
questioned (Regner et al., 2009), and a role in proinflammatory
signaling has been suggested (Afonina et al., 2011). In addition,
several lines of evidence suggest that GzmB functions indepen-
dently of perforin outside the cell (Hiebert and Granville, 2012).
Notably, extracellular GzmB occurs in the circulation and in-
creases during infection, inflammation, allergy, or autoimmune
disease. This soluble GzmB is most likely the result of constitu-
tive release by NK cells and CTLs in the absence of target cell
engagement (Prakash et al., 2009) or stimulated release on bind-
ing to extracellular matrix (ECM) proteins (Takahashi et al., 1991).
There are at least ten documented GzmB substrates from the
ECM (Hendel et al., 2010). Given that proteolysis of ECMcompo-
nents is important in leukocyte trafficking (Leppert et al., 1995),
we and others have proposed that GzmB potentially plays a
role in cytotoxic lymphocyte migration (Buzza and Bird, 2006;
Buzza et al., 2005; Kramer and Simon, 1987). The studies we
report here showed that GzmB contributed to cytotoxic lympho-
cyte extravasation and homing in vivo without affecting intersti-
tial motility. In vitro studies showed that it played a role in base-
ment membrane remodeling by cytotoxic lymphocytes via ECM
cleavage. A role for extracellular GzmB in cell trafficking might
partly explain its expression by other leukocyte types and nonim-
mune cells, as well as its association with several immune pa-
thologies linked to ECM degradation.
RESULTS
Impaired Homing of GzmB-Deficient Cytotoxic
Lymphocytes during Virus Infection
We infectedmicewith theattenuatednatural pathogenEctromelia
virus Hampstead egg (ECTV-HE) to examine CTL and NK cell
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given that immune cellsmust enter the cavity from the vasculature
via diapedesis and crossing the squamous epithelium lining the
peritoneal wall. Wild-type (WT) or Gzmb/ mice were infected
intraperitoneally (i.p.), and spleens and peritoneal exudates were
collected and analyzed postinfection. Numbers and proportions
of NK cells and CTLs in peritoneal exudate cells (PECs) were
compared to splenic populations, which acted as controls.
As indicated by analysis of total CD8+ T cells or a subset of
virus-specific CTLs marked by EV-Kb tetramer (Regner et al.,
2009), peritoneal exudates from WT mice showed substantial
accumulation of CTLs by 6 days after infection, but this was
completely abrogated in Gzmb/ mice (Figure 1A). No differ-
ence was observed in the proportion or number of splenic
CTLs, suggesting that the decrease in the peritoneum was a
result of defective recruitment. A recruitment deficit was also
observed for NK cells (Figure 1B). Spleens from WT and
Gzmb/ mice contained similar numbers of splenocytes, as
well as similar total and proportional numbers of NK cells at all
time points. However, although there was a substantial increase
in peritoneal NK cells in WT mice at days 4 and 6, only a slight
increase was observed in Gzmb/ mice. Thus, both CTLs and
NK cells lacking GzmB appear unable to efficiently extravasate
in the context of viral infection.
To determine whether this recruitment deficit is cell autono-
mous, we adoptively transferred NK cells from WT or Gzmb/
mice into WT Ptprca congenic recipient mice (Figure 1C). In
this normal environment,Gzmb/NK cells still displayed defec-
tive recruitment to the peritoneal cavity during infection, showing
that the defect is intrinsic to themigrating cell and does not result
from altered external stimuli.
GzmB-Deficient CTLs Exhibit Decreased Homing
in Models of Inflammation
The Gzmb/ cytotoxic lymphocyte homing defect observed
during ECTV-HE infection was also observed in models of non-
antigen-specific inflammation (Figure 2). In the mechanical
tape-strip assay (Shulman et al., 2011), activated WT oval-
bumin-tcr-I (OT-I) or Gzmb/ OT-I donor CTLs were adoptively
transferred into Ptprca recipient mice after local inflammation
hadbeen induced inoneear.Weusedspleenas thecontrol organ
to account for the number of systemic OT-I cells and compared
the noninflamed ear to the irritated ear to ensure that an inflam-
matory response had occurred. The ratio of donor cells in the
ear todonor cells in the spleen showedsignificantly lessGzmb/
CTL homing thanWT cell homing to the inflamed ear (Figure 2A).
We also adapted the contact-hypersensitivity model (Gaspari
and Katz, 1991) to examine the recruitment of WT and Gzmb/
CTLs in vivo. Lymphocytes from either WT or Gzmb/ mice
were labeled and adoptively transferred into sensitized WT
recipient mice. A local inflammatory response was induced
chemically, and recruitment of labeled lymphocytes to the in-
flamed site (ear) was compared to that of control tissue (un-
treated ear). As shown in Figure 2B, compared to recruitment
of control cells, recruitment of Gzmb/ lymphocytes to the in-
flamed ear was significantly impaired.
To examine NK cell recruitment during inflammation, we differ-
entially labeled naive WT and Gzmb/ NK cells, coadoptively
transferred them into WT recipients, and peritoneally injectedIthem with poly(I:C). Using accumulation of donor cells within
the spleen as a comparison, we examined peritoneal exudate
for labeled donor NK cells. Significantly fewer Gzmb/ NK cells
thanWT cells were recovered in the peritoneal cavity (Figure 2C).
Similar results were obtained with cells from animals lacking
GzmA, GzmB, and GzmM (Gzma/Gzmb/Gzmm/; Fig-
ure 2C), suggesting that GzmA and GzmM do not contribute to
cytotoxic lymphocyte recruitment (see also Figure 4Aii).
GzmB Contributes to CTL Transmigration in
Postcapillary Venules
To directly visualize the behavior of Gzmb/ CTLs within in-
flamed venules, we performed intravital imaging in a sterile
inflammationmodel (Shulman et al., 2011). Adoptively transferred
WT and Gzmb/ CTLs were covisualized in dermal vessels of
the ear. WT and Gzmb/ CTLs showed similar rolling fractions
and mean rolling velocities (Figures 3Ai and 3Aii; Figure S1 and
Movie S1, available online), suggesting similar engagement with
E- and P-selectins on the endothelium. Furthermore, there was
no significant difference in firm adhesion between the two popu-
lations (Figure 3Aiii), indicating identical binding of integrins on
CTLs to their respective endothelial ligands. We did not observe
transmigration of CTLs during 30 min live imaging sessions.
Nevertheless, whole-mount stains from ear skin samples ob-
tained 6 hr posttransfer revealed fewer Gzmb/ than WT CTLs
in the dermis, suggesting that GzmB expression facilitates
lymphocyte exit into the interstitium (data not shown).
To directly investigate the role of GzmBCTLs in transmigration,
we imaged differentially labeled Gzmb/ and WT CTLs in in-
flamed cremaster muscle by multiphoton microscopy (Hyun
et al., 2012). This model allows precise application of proinflam-
matory mediators and covisualization of differentially labeled
CTLs in the same postcapillary venules.We found that extravasa-
tion of CTLs was rare but invariably followed prolonged adher-
ence of the cells to the endothelium. To capture sufficient extrav-
asation events for statistical comparison, we therefore recorded
long3Dsequencesof single fields for up to6 hr (Figure3B;Movies
S2 and S3). Our imaging revealed that WT CTLs extravasated in
significantly higher numbers than Gzmb/ CTLs (extravasation
fractions: 0.48 for WT versus 0.11 for Gzmb/, p = 0.0064; Fig-
ure 3B). We also observed that once penetration started, most
WT CTLs smoothly and rapidly translocated through the vessel
wall (Figure 3Bi; Figure S2A; Movie S2). By contrast, Gzmb/
CTLs usually remained firmly attached to the vasculature wall;
they sometimes projected lamellipodia into the extravascular
space but ultimately retreated into the lumen (Figure 3Bii; Fig-
ure S2A; Movie S3). Furthermore, transmigration appeared to
take longer for Gzmb/ than for WT cells (average 77 min for
Gzmb/ versus 28 min for WT), although the small number of
extravasation events recorded for Gzmb/ CTLs did not allow
statistical comparison (Figure S2C). Together, these data demon-
strate that GzmB expression by CTLs is dispensable for rolling
and firm adhesion but plays an important role in crossing the
vessel wall, the final step in diapedesis.
GzmB Is Not Required for Interstitial Migration
To investigate thecontributionofGzmBto interstitialmovementof
cytotoxic lymphocytes, we compared the motility of WT and
Gzmb/CTLs in a tumormicroenvironmentbyusingmultiphotonmmunity 41, 960–972, December 18, 2014 ª2014 Elsevier Inc. 961
(legend on next page)
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Figure 2. Deficient Recruitment of Gzmb–/–
Cytotoxic Lymphocytes during Inflammation
(A)Homingof activatedWTorGzmb/OT-ICTLs in
a tape-strip inflammation model. Shown is the ratio
of donor cells in the tape-stripped ear to donor cells
in spleen 24 hr after stimulation. The graph shows
mean ± SD of data from two separate experiments.
(B) Homing of naive WT or Gzmb/ lymphocytes
in a contact-hypersensitivity inflammation model.
Shown is the ratio of donor cells in the 2,4,6-trini-
trochlorobenzene (TNCB)-treated ear to donor
cells in the untreated ear 24 hr after elicitation. The
graph shows mean ± SE of data pooled from eight
experiments.
(C) Homing of WT or Gzma/Gzmb/Gzmm/ NK cells in response to poly(I:C). Shown is the ratio of donor cells recovered from the peritoneal cavity to donor
cells in spleen 48 hr after poly(I:C) administration. The graph shows mean ± SE of data pooled from three experiments.
Immunity
GzmB Expedites Cytotoxic Lymphocyte Extravasationtime-lapsemicroscopy. As shown in Figure 3Ci, there was no dif-
ference in tumor homing betweenWT andGzmb/ CTLs, which
is consistent with the compromised, and hencemore permissive,
nature of barriers between vascular and tumor tissue (Hashizume
et al., 2000). We analyzed movies of motile CTLs to measure
cellular mean speed and displacement (Figures 3Cii and 3Ciii;
Movies S4 and S5). No differences were observed between WT
andGzmb/CTLs inanyof theseaspectsof interstitialmigration,
suggesting that GzmB is not required to remodel the extravas-
cular ECM to promote CTL motility.
GzmB Contributes to Migration of Human CTLs through
Basement Membrane In Vitro
To gain insight into the molecular and cellular aspects of GzmB-
mediated transmigration, we performed in vitromigration assays.
Primary human peripheral-blood CTLs placed in the upper
compartment of a Boyden chamber (Transwell) transmigrated
freely through the basal filter toward the chemokine SDF-1a,
which was added to the lower chamber (Zhang et al., 2006).
Progress was impeded if Matrigel, a widely used model base-
ment membrane (Benton et al., 2011; Kleinman and Martin,
2005), was used to coat the filter. Progresswas further decreased
if cells were pretreated to inhibit either granule release (degranu-
lation) or GzmB activity (Figure 4Ai). The degranulation inhibitor
concanamycin A (CMA) reduced chemokine-directed CTL trans-
migration through Matrigel by 43%. Compound-20 (C-20), the
specific cell-permeable inhibitor of human GzmB (Willoughby
et al., 2002), caused a 57% decrease in transmigration, which
correlated well with the 60% inhibition of cellular GzmB enzy-
matic activity caused by C-20 pretreatment (data not shown).
Thus, GzmB contributes to CTL transmigration in vitro.
Migration of Primary Murine CTLs through Basement
Membrane Is Facilitated by Both Granular and
Extragranular GzmB
Using cells from three different granzyme-deficient mouse
strains (Gzma/,Gzmb/, andGzma/Gzmb/), we showedFigure 1. Gzmb–/– Mice Exhibit a Cell-Autonomous Cytotoxic Lymphoc
WT or Gzmb/ mice (n = 3–4) were infected i.p. with ECTV-HE, and spleens an
(A and B) CTL (A) and NK cell (B) recruitment to the peritoneum was measured as
the spleen.
(C) Donor WT and Gzmb/ NK cells were adoptively transferred to congenic rec
were assessed 4 days postinfection. The graph shows mean ± SE of data from t
Ithat CTLs had a pronounced defect in transmigration through
Matrigel in the absence of GzmB, but not in the absence of the
closely related protease GzmA (Figure 4Aii). Use of Matrigel
stripped of growth factors and other soluble components
did not alter the result, suggesting that cytotoxic lymphocyte
migration does not involve GzmB-mediated activation or release
of ECM-embedded signaling molecules (data not shown).
Importantly, in the absence of basement membrane, there
was no defect in chemokine-driven motility of Gzmb/ CTLs
(Figure 4Aiii).
Jinx mutant mice possess a truncated, nonfunctional version
of UNC13D, which is an important component of the granule
exocytosis machinery. Thus, degranulation in Jinx lymphocytes
is severely compromised (10% of WT cells; Crozat et al.,
2007). We showed that analogous to transmigration of CMA-
treated human CTLs (Figure 4Ai), transmigration of Jinx CTLs
through basement membrane decreased by half in comparison
to WT CTLs (Figure 4Aii). Together, these data support the
idea that GzmB facilitates CTL migration via basement mem-
brane degradation in vitro.
CTLs Moving through Basement Membrane Release
Active GzmB
Granzymes stored in granules are quiescent (inactive) as a
result of the acidic lumenal environment. Upon receptor stimu-
lation, they are released from granules and gain activity in a
process involving granule mobilization and polarization followed
by fusion with the plasma membrane (de Saint Basile et al.,
2010). Granzyme release from static CTLs in response to puri-
fied ECM components has been reported (Takahashi et al.,
1991), but we sought to examine whether this also occurs in
cells moving on or through basement membrane via degranula-
tion. Mouse CTLs were placed on Matrigel, and the distribution
of GzmB-containing granules was assessed (Figure 4B). Gran-
ules were marked by a GzmB-mCherry fusion protein (Bird
et al., 2010) introduced by retroviral transduction. GzmB-con-
taining granules polarized toward the cell-matrix interface,yte Recruitment Defect in Response to Ectromelia Virus
d PECs were collected postinfection (p.i.).
CD8+EV-Kb+ and NK1.1+ cells present in peritoneal exudate as compared to in
ipients (n = 9–10) prior to ECTV-HE infection. Donor cells in PECs and spleen
hree experiments.
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Figure 3. GzmB Facilitates CTL Extravasation, but Not Interstitial Migration
(A) Interaction of adoptively transferred WT OT-I and Gzmb/ OT-I CTLs with vessel walls was measured by intravital microscopy of inflamed ear venules
(see also Figure S1 andMovie S1). (i) Mean T cell rolling velocity. Each dot represents a single event; 50 events were analyzed per group. (ii and iii) Rolling fraction
(ii) and sticking fraction (iii). Each dot represents data from a single mouse (n = 3 mice). Statistical analysis was performed with a Mann Whitney two-tailed t test
(n = 3 mice). n.s. indicates ‘‘not significant.’’
(B) CTL extravasation was visualized by intravital microscopy of inflamed cremaster muscle. The numbers of events analyzed and the corresponding extrava-
sation fractions for each mouse are in Figure S2A. (i) 3D time-lapse images of differentially labeled WT (green) and Gzmb/ (red) CTLs moving in a postcapillary
venule (gray) highlighted by Evans Blue staining (endothelial cells are indicated with dotted lines). The scale bar represents 10 mm. The upper row shows an
extravasating WT CTL (see also Movie S2), and the lower row shows a Gzmb/ cell that extends its front into the extravascular space but then retracts into the
vascular lumen (see also Movie S3). (ii) Proportions of WT and Gzmb/ cells extravasating within individual animals (populations originating from a particular
animal are joined by a line). (iii) Average extravasation indexes. Statistical analysis was performed with a Mann Whitney two-tailed t test (n = 7 mice). See also
Figure S2.
(C) Interstitial migration of CTLs. (i) WT orGzmb/OT-I CTLswere transferred into tumor-bearingmice (n = 5). Tumors were explanted 2–3 days posttransfer, and
CTLs were observed via two-photon microscopy. Shown are CTL numbers in tumors 3–4 days posttransfer in relation to splenic CTLs. (ii and iii) Mean speed (ii)
and displacement (iii) betweenWT andGzmb/CTLs were measured (n = 700–800 cells were examined over four separate experiments, each with at least three
tumors per group). See also Movies S4 and S5.
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contents toward the cell-matrix interface (Figure 4B, gray
arrowheads).
CTLs embedded in Matrigel spontaneously migrate (Leppert
et al., 1995). By incorporating a diffusible quenched fluorescent
GzmB peptide substrate into the matrix, we demonstrated that
foci of active GzmB were mainly in the uropod and midbody of
embedded migrating cells (Figure 4Ci). Up to five foci per WT
cell, far fewer than the total number of granules, were apparent
at any one time, indicating an ordered process involving sequen-
tial granule fusion and ongoing release of GzmB (Figure 4Cii). By
contrast, GzmB-deficient cells exhibited very low, nonpunctate
background substrate cleavage always associated with mem-
brane blebs from the uropod (Figure 4C). This most likely re-
sulted from caspase-8, which has a similar specificity to GzmB
and can also cleave this peptide substrate.
To confirm that granzymes are released from CTLs in
response to ECM contact, we cultured cells on either uncoated
or Matrigel-coated surfaces and assessed cell lysates and cul-
ture supernatants for GzmA (benzyloxycarbonyl-L-lysine thio-
benzyl [BLT] esterase) activity. We assessed total stored and
releasable BLT esterase by treating controls with the degranulat-
ing agents phorbol myristate acetate (PMA) and calcimycin.
There was a small but significant increase in extracellular BLT
esterase activity from CTLs on Matrigel (Figure 4D), indicating
that granzymes are released in response to the ECM. Impor-
tantly, Jinx CTLs, which cannot efficiently degranulate (Crozat
et al., 2007), showed no stimulation of BLT esterase release by
Matrigel (Figure 4D).
GzmB-Dependent Basement Membrane Remodeling by
Migrating Cytotoxic Lymphocytes
We used live cell confocal imaging and scanning electron micro-
scopy (SEM) to further study the interaction of migrating CTLs
with basement membrane. Cells moving across Matrigel altered
the surface and left a visible trail, suggesting that the matrix had
been modified (Figure 5A; Movie S6). If embedded in the matrix
and induced to move along a chemokine gradient, the cells bur-
rowed to form two distinct types of spatial structures, which we
termed ‘‘tunnels’’ and ‘‘nests’’ (Figure 5Bi; Movie S7). Gzmb/
CTLs formed fewer tunnels and appeared in nests more often
than WT CTLs (Figure 5Bii). The burrows created by Gzmb/
CTLs were also significantly smaller in volume than those
created by WT CTLs (Figure 5Biii).
Viewed by SEM, CTLs placed on matrix over a source of che-
mokine exhibited morphological characteristics of migrating
cells (e.g., polarization; Figure 5Ci) and appeared to clear the sur-
rounding matrix and/or burrow under it (Figure 5Cii). Fewer
Gzmb/ CTLs exhibited clearing, although cell polarization
and burrowing were unaffected (Figure 5Cii). Taken together,
these results indicate that migrating cytotoxic lymphocytes use
GzmB to alter (remodel) basement membrane structure.
GzmB Cleaves Basement Membrane Components
Matrigel is the ‘‘gold-standard’’ basement membrane model
(Benton et al., 2011; Kleinman and Martin, 2005). Viewed by
SEM, Matrigel is a dense, fibrillar structure (Abrams et al.,
2000; Van Goethem et al., 2010) that covers the pores in the
Transwell membrane and must be cleared or remodeled toIallow cells into the lower chamber (Figure 6Ai). However, a
formal possibility remains that cytotoxic lymphocytes might
not use GzmB to traverse a basement membrane synthesized
by cells and assembled in situ. We therefore followed estab-
lished procedures (Ferrell et al., 2011; Tammi et al., 2000) to
allow monolayers of epithelial Madin-Darby canine kidney
(MDCK) cells to produce basement membrane in Transwells.
As shown in Figure 6Ai, MDCK-cell-derived basement mem-
brane is structured differently from Matrigel in that it forms
a dense continuous sheet. Nevertheless, SEM analysis of
MDCK cell and Matrigel basement membrane in Transwells
before and after exposure to CTLs showed that the integrity
of both was significantly disrupted by CTLs, which exposed
the underlying filter (Figure 6Ai). Importantly, Gzmb/ CTLs
also exhibited a transmigration deficit on MDCK cell basement
membrane (Figure 6Aii), further supporting the idea that GzmB
facilitates cytotoxic lymphocyte migration through basement
membranes in vivo.
Given that GzmBprobably contributes to cytotoxic lymphocyte
migration via basement membranemodification, we investigated
whether ECM components are cleaved by GzmB. We found that
exposure to purified recombinant GzmB disrupted Matrigel or
MDCK cell basement membrane on Transwell filters (Figure 6Bi).
Membranes were less affected by exposure to GzmB inactivated
by an alteration in its active site (mGzmBS203A), consistent with
its low residual activity (data not shown). Pretreatment of Matrigel
in Transwells with recombinantGzmBalso enhanced transmigra-
tion of Gzmb/ CTLs at a rate comparable to that seen in the
absence of matrix (Figure 6Bii).
GzmB-mediated Matrigel degradation was also demon-
strated by a proteomics approach. Matrigel was set and acet-
ylated to block free N termini and treated with GzmB; then,
newly exposed N termini were detected. Numerous cleavage
products were evident upon GzmB treatment (Figure 6C).
Although it is known that GzmB can cleave isolated ECM pro-
teins (Hendel et al., 2010), this experiment demonstrates cleav-
age of proteins in the context of a complex 3D matrix. We then
used the Protein Topography and Migration Analysis Platform
(PROTOMAP) to identify specific matrix proteins that are
directly or indirectly cleaved by GzmB (Dix et al., 2008). PRO-
TOMAP identified 300 Matrigel proteins, many of which are
cleaved by GzmB (Table S2). In addition to including the major
ECM constituents, Matrigel also contains a large number of
contaminating intracellular proteins (Hansen et al., 2009;
Hughes et al., 2010). Consistent with the documented ability
of GzmB to cleave a wide range of cytosolic substrates (Van
Damme et al., 2009), intracellular proteins composed the ma-
jority of GzmB targets identified. Nevertheless, ten of the pro-
teins cleaved by GzmB are known ECM components, and in
four a putative GzmB cleavage site could be readily identified.
These substrates are shown in Table 1 and are ordered by
decreasing similarity of the putative mouse GzmB cleavage
site to the consensus sequence motif (Kaiserman et al., 2006;
Van Damme et al., 2009). Fibrinogen-b has previously been re-
ported as a substrate of GzmB (Buzza et al., 2008), and the
indicated cleavage site has been demonstrated by N-terminal
sequencing. These results suggest that GzmB remodels base-
ment membrane during transmigration by cleaving structural
components.mmunity 41, 960–972, December 18, 2014 ª2014 Elsevier Inc. 965
Figure 4. GzmB Expedites Cytotoxic Lymphocyte Migration through Model Basement Membrane In Vitro and Is Released from Granules of
Mobile Cells
(A) (i) Transmigration of humanCTLs treatedwith CMA or C-20 to inhibit GzmB release or activity, respectively. Shown ismean ± SE of data from five experiments.
(ii) Transmigration of Gzma/, Gzmb/, Gzma/Gzmb/, or Jinx CTLs. Shown is mean ± SE of data from more than three experiments. (iii) Transmigration of
WT and Gzmb/ CTLs in the absence of Matrigel. Shown is mean ± SE of data from two experiments.
(B) Representative images of GFP (green)- and mCherry-GzmB (magenta)-expressing CTLs migrating on CellTrace Violet-labeled Matrigel (blue). Localization of
GzmB-containing granules is viewed from the top (i and ii) and from the side (iii). White arrowheads indicate lamellipodia (lamell.; leading end of the cell), and gray
arrowheads indicate the uropod (lagging end). The scale bar represents 7 mm.
(legend continued on next page)
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It is emerging that granzymes do more than destroy cells
(Joeckel and Bird, 2014). We have shown here that the key cyto-
toxin GzmB has an additional function as an important contrib-
utor to cytotoxic lymphocyte extravasation and hence homing.
This is consistent with the accepted role of proteolysis in leuko-
cyte extravasation, which can also involve neutrophil elastase,
matrix metalloproteases (e.g., MMP-1, MMP-2, MMP-8, MMP-
9, and MMP-13), and cathepsins B, G, K, and L.
Taken together, our data suggest that extracellular-GzmB-
mediated cleavage and/or release of basement membrane com-
ponents (remodeling) assists cytotoxic lymphocytes to cross the
endothelium during transmigration. It is unlikely that GzmB is
required for initial penetration of the vessel wall, given that
GzmB-null CTLs can extend lamellipodia through it and retain
the ability to extravasate, albeit very poorly. Rather, it is likely
that remodeling by GzmB facilitates passage of the cytotoxic
lymphocyte body—containing the relatively rigid nucleus—
through the breach. (By contrast, neutrophils with their multilob-
ular nuclei can presumably squeeze through smaller holes and
require little or no basement membrane remodeling after pene-
tration.) That GzmB is not required for CTL homing to tumors
or for interstitial motility can be explained by (1) the abnormal
structure of tumor vasculature, which is more permissive to
CTL extravasation (Boissonnas et al., 2007; Hashizume et al.,
2000), and (2) the distinct, amoeboid-like lymphocyte movement
within tissues, which does not rely on ECMproteolysis (Weninger
et al., 2014).
Previous studies showing ECMcleavagebyGzmBhave gener-
ally used purified individual protein substrates in soluble ormatrix
conformations (for example, see Buzza et al., 2005). We have
extended these observations by demonstrating GzmB-mediated
cleavage of complex, intact basement membrane and by iden-
tifying GzmB substrates within it. The presence of substrates
lacking strong GzmB cleavage motifs can be explained by (1)
GzmB-mediated activation of other proteases within Matrigel
via zymogen conversion or inhibitor degradation or (2) exosite
GzmB-substrate interactions, which allow cleavage at an osten-
sibly suboptimal site, as previously documented for GzmB-medi-
ated cleavage of vitronectin (Buzza et al., 2005) and supported by
subsequent proteomics studies (Plasman et al., 2011; Van
Damme et al., 2009).
Cytotoxic lymphocytes unable to degranulate are impaired in
migration but to a lesser extent than GzmB-null cells. This
discrepancy suggests that some active GzmB is released via
an alternative pathway or that zymogen GzmB released by the
default secretory pathway is activated extracellularly. Previously,
we showed that human and mouse CTLs constitutively release
both active and zymogen GzmB in the absence of targets via
degranulation and the default secretory pathway (Prakash
et al., 2009). We have also shown that in addition to cathepsin(C) GzmB activity is associated with mobile cytotoxic lymphocytes. (i) Represe
containing the diffusible quenched fluorescent GzmB substrate z-IETD-R110. Th
are displayed as consecutive z planes 1 mmapart. (ii) Scoring of GzmB release by
pericellular substrate cleavage (an arrow points to an example in i). Fluorescent
(D) Degranulation of WT or Jinx CTLs in response to Matrigel. Data are expressed
Shown is mean ± SE of data from three experiments.
IC, which normally activates GzmB, cathepsin H also possesses
proGzmB convertase activity, illustrating that other activators of
GzmB exist (D’Angelo et al., 2010). This, together with the data
presented here, supports the existence of an extragranular
pathway to activation of zymogen GzmB.
Recent studies have revealed proinflammatory roles for
GzmA, GzmK, and GzmM, but not GzmB, via cytokine modula-
tion following lipopolysaccharide challenge (reviewed in Joeckel
and Bird, 2014). It has also been reported that GzmB (along with
calpain-1, elastase, and mast cell chymase) cleaves the alpha
subunit of interleukin-1 (IL-1) to enhance proinflammatory effects
(Afonina et al., 2011). This can occur either intracellularly during
target cell killing by cytotoxic lymphocytes or as a consequence
of IL-1 released by necrotic cells encountering GzmB in the
extracellular space. Therefore, there is a formal possibility that
GzmB might also enhance CTL migration via cytokine modula-
tion. We consider this unlikely given that our infection, inflamma-
tion, and tumor models involved adoptive transfer of WT and
Gzmb/ cytotoxic lymphocytes into WT animals. Because we
noted no difference in efficiency of recruitment of WT or
Gzmb/ CTLs to tumors, we conclude that GzmB produced
by CTLs does not modulate cytokines originating from tumor
or other cells to amplify CTL recruitment.
In closing, our finding that extracellular GzmBwas released by
infiltrating cytotoxic lymphocytes to expedite transmigration
through basement membrane provides a simple explanation
for several long-standing and puzzling observations: (1) the in-
crease in circulating GzmB in several inflammatory and infec-
tious disease states (Buzza and Bird, 2006), (2) the links between
GzmB and atherosclerotic lesion severity (Hendel et al., 2010)
and between GzmB and impaired wound healing (Hiebert
et al., 2013), and (3) the expression of GzmB by other noncyto-
toxic immune cell types, nonimmune cells, and neoplastic cells.
It could be that GzmB is used by a variety of cell types to assist
basement membrane remodeling.
EXPERIMENTAL PROCEDURES
Mice
All mice were on the C57BL6/J background. Gzma/, Gzmb/, Gzma/
Gzmb/, and Gzma/Gzmb/Gzmm/ lines were from the Peter MacCal-
lum Cancer Centre or the Animal Services Division of Australian National Uni-
versity. OT-I strains were bred in house at the Centenary Institute. Jinx mice
were from the Mutant Mouse Regional Resource Center (University of Califor-
nia, Davis), and Ptprca mice were from the Animal Resources Centre (Canning
Vale) or the Walter and Eliza Hall Institute (Melbourne). Albino C57BL/6
(C57BL/6-Tyrc-2J) mice were from the Jackson Laboratory. All experiments
were conducted under the appropriate animal ethics regime.
Cell Culture
Human CTLs were isolated from peripheral-blood mononuclear cells from
informed human volunteers (Monash University Standing Committee on Ethics
in Research Involving Humans project no. CF07/0849). CTLs were isolated via
magnetic-activated cell separation (MACS, Miltenyi Biotec) based on CD8ntative images of mouse WT and Gzmb/ CTLs migrating through Matrigel
e scale bar represents 10 mm. Single-cell images were taken as 3D stacks and
migrating CTLs, as indicated by cell-associated fluorescent puncta arising from
signal (low versus high) was assigned in relation to background intensity.
as a percentage of total BLT esterase cleavage in cell lysate and supernatant.
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Figure 5. GzmB Facilitates Cytotoxic Lymphocyte Migration via Basement Membrane Remodeling
(A) Snapshots from a representative live cell movie (Movie S6) of a GFP-expressing CTL moving across fluorescently labeled Matrigel show remodeling of the
ECM surface.
(B) (i) Representative 3D reconstructions from two experiments of characteristic spaces, termed ‘‘tunnels’’ and ‘‘nests,’’ created by cytotoxic lymphocytes
moving through Matrigel in response to CXCL10. (ii) Proportion of WT and Gzmb/ CTLs showing tunnels or nests (see also Movie S7). (iii) Quantitation of
burrows generated by individual cells.
(C) (i) SEM of cytotoxic lymphocytes cultured on Matrigel in the presence of a CXCL12 gradient and quantitation of cytotoxic lymphocyte polarization. (ii) Scoring
of matrix clearing and burrowing by cytotoxic lymphocytes on Matrigel-CXCL12 via SEM. Scale bars represent 15 mm.
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GzmB Expedites Cytotoxic Lymphocyte Extravasationexpression after CD56+ cell depletion. CTLs were cultured in complete RPMI-
1640 medium (10% heat-inactivated fetal calf serum [FCS], 2 mM glutamine,
50 U/ml penicillin, 50 mg/ml streptomycin, 90 mM mercaptoethanol, 0.1 mM
MEM nonessential amino acids, and 1 mM sodium pyruvate; Gibco) with968 Immunity 41, 960–972, December 18, 2014 ª2014 Elsevier Inc.5 mg/ml concanavalin A and 100 U/ml IL-2 for 72–120 hr. CTLs were
70.11% ± 13.90% CD3+ and 74.14% ± 8.01% CD8+ (data not shown).
GzmB secretion and activity were inhibited by 4 hr pretreatment with
100 ng/ml CMA and 100 mM C-20, respectively, at 37C.
Figure 6. GzmB Facilitates Migration through Natural Basement Membrane and Cleaves Basement Membrane Components
(A) (i) SEMofMatrigel andMDCK-cell-derivedbasementmembranebefore andafterWTCTLpassage. (ii) Transmigration ofWTandGzmb/CTLs throughMDCK
cell basement membrane. The graph shows mean ± SE of data from six separate experiments. The scale bar represents 3 mm (high magnification) or 15 mm.
(B) (i) SEM of Matrigel and MDCK-cell-derived basement membrane treated with 100 nM recombinant mouse GzmB (mGzmB) or active-site mutant GzmB
(mGzmBS203A). White arrows indicate pre-existing pores no longer obscured by matrix in the Transwell membrane. (ii) Migration of Gzmb/ CTLs through
Matrigel treated with the given concentrations of exogenous recombinant GzmB. Graph shows mean ± SE of data from five separate experiments. The scale bar
represents 3 mm.
(C) Matrigel was N-terminally dimethylated and exposed to 100 nM recombinant mouse GzmB. Neo-N-termini were biotinylated, separated by SDS-PAGE, and
visualized by immunoblotting.
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GzmB Expedites Cytotoxic Lymphocyte ExtravasationMurine CTLs were derived from splenocytes via MACS selection of CD8+
cells and were cultured as described for human CTLs for 48–72 hr. Alterna-
tively, WT OT-I and Gzmb/ OT-I CTLs were stimulated in vitro with
OVA257-264 (SIINFEKL) peptide for 2 hr and cultured for 5–6 days prior to use.
MDCK cells were cultured in complete Dulbecco’smodified Eagle’smedium
(10% FCS, 2 mM glutamine, 50 U/ml penicillin, and 50 mg/ml streptomycin;
Gibco). For generation of basement membranes, confluent MDCK cell mono-
layers were maintained in Transwells for 18–22 days and then removed while
the basement membrane was left intact, as previously described (Tammi et al.,
2000).
Ectromelia Infection
Attenuated ECTV-HE was prepared as previously described (Wallich et al.,
2001). Four to five mice per group were infected i.p. with 13 103 plaque-form-
ing units of ECTV-HE in 100 ml PBS (Xu et al., 2004). At given days postinfec-
tion, mice were killed, and spleens and peritoneal exudates were isolated.
CD8+ and EV-Kb tetramer+ populations were analyzed by flow cytometry.
For NK cell adoptive-transfer experiments, NK cells were isolated from spleno-
cytes via MACS based on NK1.1 expression. Twenty-four hours prior to infec-
tion, 1 3 106 to 3 3 106 freshly isolated donor NK cells were adoptively trans-Iferred into Ptprca congenic recipient mice. Recipient mice were subsequently
infected as described above.
Tape-Strip Assay
Ptprca congenic recipient mice were anesthetized with ketamine-xylazine (80/
10mg/kg), hair was removed from the ears by depilation, and the dorsal side of
the ear was tape stripped (Shulman et al., 2011). Mice were left to recover from
anesthesia for 24 hr before adoptive cotransfer of 23 107WTOT-I and 23 107
Gzmb/ OT-I CTLs (for discriminating between populations, one population
was labeled with CMTMR, and the labeled population was alternated in suc-
cessive experiments). Mouse spleens and ears were harvested 24 hr post-
transfer, and cells were isolated from the ear skin as previously described
(Sumaria et al., 2011). Cell suspensions were stained with fluorochrome-con-
jugated antibodies against B220, CD8, CD11b, CD45, CD45.2, and CD90.2
(BD Biosciences) for the identification of donor cells and were analyzed by
flow cytometry.
Contact-Hypersensitivity Assay
This assay was adapted from Gaspari and Katz, 1991. Naive WT or Gzmb/
lymphocytes were labeled with either PKH-26 or CellTracker-Orange CMRAmmunity 41, 960–972, December 18, 2014 ª2014 Elsevier Inc. 969
Table 1. GzmB-Directed Cleavage of Basement Membrane Proteins in Matrigel
Accession Number Protein Description Putative mGzmB Cleavage Site
Q08879-2 fibulin-1C matrix-associated glycoprotein 393 FYFD
Q3UQ28 peroxidasin basement membrane component 1273 ILCD
Q61292 laminin beta-2 basement membrane component 264 NLLD
Q8KOE8 fibrinogen beta blood coagulation factor 227 IQPD
P07214 SPARC, osteonectin, BM-40 ECM scaffold no putative mGzmB cleavage site
found at event; position 220
P08122 collagen IV alpha-2 basement membrane component no putative mGzmB cleavage site
found at event; position 1,500
O88322 nidogen-2 basement membrane scaffold cleaved at multiple sites
E9Q557 desmoplakin desmosome-associated protein cleaved at multiple sites
P02463 collagen IV alpha-1 basement membrane component ND
Q99JR5 tubulointerstitial nephritis antigen-like basement membrane component ND
The following abbreviations are used: ECM, extracellular matrix; and ND, no data (insufficient data for prediction of cleavage site).
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GzmB Expedites Cytotoxic Lymphocyte Extravasation(Invitrogen). A total of 23 107 labeled cells in 100 ml PBS were transferred into
WT recipients. Seven percent 2,4,6-trinitrochlorobenzene (TNCB) was applied
to a shaved flank (sensitization dose). Six days later, an elicitation dose of 1%
TNCB was applied to both sides of the left ear. After 24 hr, ears and spleen
were analyzed for the presence of donor cells by flow cytometry.
Poly(I:C)-Induced NK Cell Recruitment to the Peritoneal Cavity
Naive WT and Gzmb/ NK cells were labeled with either CellTracker-Orange
CMRA or CellTrace Violet (Invitrogen). A total of 13 107 donor NK cells of each
genotype were cotransferred into WT recipients. After 24 hr, recipient mice
were injected i.p. with 100 mg poly(I:C), and after 48 hr spleens and peritoneal
exudates were analyzed by flow cytometry for the presence of donor NK cells.
Intravital Imaging of CTL Diapedesis
WT and Gzmb/ OT-I CTLs (5–6 days postactivation) were labeled in serum-
free RPMI at 37C with CFSE, CellTrace violet (6.7 mM, 1 3 107 cells/ml for
20 min), or CMTMR (5 mM, 1 3 107 cells/ml for 15 min) (Life Technologies).
In the ear inflammation model, ears of albino C57BL/6mice were tape stripped
18–24 hr prior to imaging. CTLs were mixed at a 1:1 ratio (Figure S1), injected,
and imaged as previously described (Shulman et al., 2011). CTL rolling was
defined as the movement of cells along the vessel wall at a lower velocity
than free-flowing cells. Sticking was defined as CTL arrest for more than
30 s without further movement greater than one cell diameter. The rolling frac-
tion was the number of rolling cells out of the total number of cells observed;
the rolling velocity was the distance traveled by the cells in blood vessels
(mm) as a function of time (s); the sticking fractionwas the number of cells stick-
ing in blood vessels out of the total number of cells observed; and the extravas-
cular fraction was the number of cells in the interstitium out of the total number
of cells observed.
In the cremaster muscle model, C57BL/6 mice were anesthetized by intra-
peritoneal injection of ketamine-xylazine (80/10 mg/kg) with regular half-
dose administrations. Mice were injected intrascrotally with 0.5 mg TNF-a
(0.25 mg in 200 ml per testicle) 1–2 hr before surgery. Anesthetized mice were
cannulated (right carotid artery) and placed on a customized stage for main-
taining body temperature, and cremaster muscles were surgically exposed.
The tissue was immersed in buffer containing 10 nMCXCL10 at 37C, covered
with a glass coverslip, and sealed with vacuum grease. Immediately before im-
aging, 13 108 labeled cells (WT andGzmb/OT-I CTLs at a 1:1 ratio and pre-
viously checked for GzmB expression; Figure S2B) were injected via the
cannula together with Evans Blue (50–100 ml at 33.3 mg/ml) to highlight blood
vessels. Imaging was performed with a multiphoton LaVisionBioTec micro-
scope with a motorized intravital stage (163 water-dipping objective [Nikon
CFI75 LWD 163W], 0.80 numerical aperture, and 3.0 mm working distance).
MaiTai HP and MaiTai Insight laser systems were tuned to 790 nm (0.81 W
infrared [IR] source power) and 1,080 nm (1.35 W IR source power), respec-
tively. Chosen fields of view encompassed postcapillary veins 20–60 mm in970 Immunity 41, 960–972, December 18, 2014 ª2014 Elsevier Inc.diameter (Hyun et al., 2012), and 3D stacks were acquired at 1 min intervals
for up to 6 hr. As a control for potential labeling artifacts affecting CTL behavior,
dyes (CMTMR and CellTrace Violet) were alternated between the two CTL
populations in consecutive experiments.
For calculating extravasation fractions, the proportion of CTLs exiting the
vasculature was counted in relation to the total number of cells firmly engaged
with the vascular wall. Firm engagement was defined as a cell displaying little
or no displacement over 20 min or longer. Most extravasating cells initiate
transmigration 20min after arrest. Successful extravasation involved complete
translocation of the cell body into the extravascular space. For minimizing bias
during image acquisition and analysis, the identity of labeled CTLs was un-
masked only after analysis was complete. 3D images were processed with
Imaris, Volocity, and ImageJ.
Tumor Homing
OT-I T cells were expanded, and noncognate tumors were established and ex-
planted for ex vivo observation of infiltrating OT-I CTLs via two-photon micro-
scopy as previously described (Manjunath et al., 2001; Mrass et al., 2006).
Mean speed and displacement were used for assessing migration of individual
CTLs. Mean speed measures the mean velocity of vectors in a defined track.
Displacement is the distance from the origin (time 0: point A) to the final point in
the track (point X) and is normalized for the duration (seconds) of each track.
Transwell Migration Assay
Transwell (6.5 mm, 5 mm pore size; Corning) membranes were coated with
either 1.5 mg/ml Matrigel (BD Biosciences) in a total volume of 50 ml or
MDCK-cell-derived basement membrane as described above. Transwells
were placed in a 24-well tray containing 600 ml complete medium per well
with or without 100 ng/ml SDF-1a (Sigma-Aldrich). Cells were resuspended
in 200 ml complete medium and added to the top chamber. After incubation
for 16 hr at 37C, cell transmigration to the bottom chamber was quantitated
by CellTiter-Glo Luminescent Cell Viability Assay (Promega). Where indicated,
Matrigel was treated with recombinant mouse GzmB (mGzmB) for 24 hr prior
to assay. Data are expressed as a migration index, which is the ratio of the
number of cells that migrate in response to SDF-1a over the number of cells
that migrate in the absence of chemokine (random migration).
Fluorescence Imaging of CTL Response to Basement Membrane
OT-I CTLs retrovirally transduced with GFP and/or GzmB-mCherry (Bird et al.,
2010) were cultured on Matrigel labeled with CellTracer Violet and were
imaged with confocal microscopy. For visualization of GzmB release in a 3D
environment, OT-I CTLs expressing and lacking GzmBwere embedded inMa-
trigel containing 400 mM GzmB quenched fluorescent substrate z-IETD-R110
(Molecular Probes) and imaged by confocal microscopy. The appearance of
fluorescence, representative of substrate cleavage, was assessed for each
snapshot.
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Splenocyte-derived CTLs were incubated in the presence or absence of Ma-
trigel for 4 hr at 37C. Cells and medium were separated, cells were lysed in
1% NP-40, and lysates and supernatants were assayed for BLT esterase ac-
tivity (Takahashi et al., 1991; Takayama and Sitkovsky, 1987). Cells were
treated with 2.5 mg/ml PMA and 0.5 mg/ml calcimycin for the culture period
as a positive control.
3D Matrigel Migration and Remodeling Assay
OT-I CTLs expressing or lacking GzmB were embedded in Matrigel labeled
with DDAO-se and were imaged by confocal microscopy with CXCL10 as
theymoved along a chemokine gradient. 3D representations were constructed
from consecutive z stacks of individual CTLs and their burrows and were cate-
gorized according to shape. Z stack volumes and image sequences were
analyzed with FIJI and Volocity.
SEM
Samples were fixed in 2.5%gluteraldehyde in 0.1M sodium cacodylate pH 7.4
for R2 hr, dehydrated in a series of increasing ethanol concentrations, and
critical-point dried by hexamethyldisilazane (ProSciTech). After being coated
with gold, samples were imaged with a Hitachi S570 scanning electron micro-
scope (Monash Micro Imaging). Cells were scored from six random fields for
polarization and interaction with the underlying matrix.
ECM Cleavage Assay
ECM protein was N-terminally dimethylated with 40 mM formaldehyde and
20 mM sodium cyanoborohydride. Blocking reagent was quenched with
100 mM glycine, and samples were treated with 100 nM protease overnight
at 37C. Neo-N-termini were biotinylated with 1 mg/ml sulfo-NHS-SS-biotin
for 2 hr at ambient temperature. Protein was collected into an appropriate
buffer and analyzed by SDS-PAGE and immunoblotting. Biotinylation was de-
tected with streptavidin-HRP (Silenus).
PROTOMAP
Matrigel was treated with either 100 nM recombinant mouse GzmB or buffer
alone overnight at 37C. Samples were then submitted to PROTOMAP anal-
ysis (Dix et al., 2008). GzmB cleavage-site motifs were identified with
consensus sequences generated from a published phage display (Kaiserman
et al., 2006) and proteomic (Van Damme et al., 2009) data sets.
Statistical Analyses
Data were assessed for normal distribution, and when only two data sets were
compared, significance was tested with a two-tailed Student’s t test or two-
tailed Mann-Whitney’s t test. Error bars indicate mean ± either SD or SE as
indicated.
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